...
首页> 外文期刊>Journal of Cancer Therapy >Vascular Invasion, Satellite Nodules and Absence of Tumor Capsule Strongly Correlate with Disease-Free Survival and Long-Term Outcome in Patients Resected for Hepatocellular Carcinoma
【24h】

Vascular Invasion, Satellite Nodules and Absence of Tumor Capsule Strongly Correlate with Disease-Free Survival and Long-Term Outcome in Patients Resected for Hepatocellular Carcinoma

机译:肝细胞癌切除患者的血管浸润,卫星结节和肿瘤胶囊的缺乏与无病生存率和长期结局密切相关

获取原文

摘要

Background: Hepatocellular carcinoma (HCC) is one of the most common cancer in the world. Liver resection (LR) is the most used therapy in well compensated liver cirrhosis and maybe used as a first-line treatment. Aim of the study is to evaluate survival rates in patients who underwent LR for HCC and to identify risk factors able to influence the prognosis. Material/Method: A retrospective study was carried out in 115 patients whounderwent LR for HCC. We evaluated overall and disease-free survival rates at 1, 3 and 5years (y) and a series of variables included: type of resection, clamping, blood loss, transfusions, tumor size, presence of capsule, satellite nodules and vascular invasion. Results: The 1-, 3-, 5-y survival rates were 90.2%, 67% and 52.7%, and disease-free survival rates were 75.3%, 44.7% and 28.4%, respectively. We have found presence/ absence of capsulated tumor (p = 0.05), satellite nodules (p = 0.004) and vascular invasion (p = 0.001) as factors able to influence the overall survival and the disease-free survival (p = 0.04 for capsulated tumor, p = 0.01 for satellite nodules and p = 0.006 for vascular invasion). Conclusion: LR is the best therapeutic option for HCC when liver transplantation is contraindicated, with good survival rates. Presence of capsule, satellite nodules and vascular invasion are the most important factors able to influence the prognosis.
机译:背景:肝细胞癌(HCC)是世界上最常见的癌症之一。肝切除术(LR)是补偿良好的肝硬化最常用的疗法,可能被用作一线治疗。该研究的目的是评估接受LR进行HCC的患者的生存率,并确定能够影响预后的危险因素。材料/方法:回顾性研究在115例接受LR的HCC患者中进行。我们评估了1年,3年和5年的总体生存率和无病生存率(y),并评估了一系列变量,包括:切除类型,钳夹,失血,输血,肿瘤大小,包膜存在,卫星结节和血管浸润。结果:1、3、5年生存率分别为90.2%,67%和52.7%,无病生存率分别为75.3%,44.7%和28.4%。我们发现存在/不存在囊性肿瘤(p = 0.05),卫星结节(p = 0.004)和血管浸润(p = 0.001)是能够影响总体生存和无病生存率的因素(p = 0.04)肿瘤,卫星结节p = 0.01,血管浸润p = 0.006)。结论:禁忌肝移植时,LR是肝癌的最佳治疗选择,生存率高。包膜的存在,卫星结节和血管浸润是影响预后的最重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号